Bioavailability Study of Fixed Dose Combination (FDC) Dutasteride and Tamsulosin Hydrochloride (HCl) Relative to One Dutasteride and One Tamsulosin HCl Tablet in Healthy Male Subjects
Condition:   Prostatic HyperplasiaInterventions:   Drug: FDC capsule of dutasteride and tamsulosin;   Drug: Dutasteride soft gelatine capsule and tamsulosin HCl oral disintegrating tabletSponsor:   GlaxoSmithKlineNot yet recruiting - verified July 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 23, 2015 Category: Research Source Type: clinical trials

Bioavailability Study of Fixed Dose Combination (FDC) Dutasteride and Tamsulosin Hydrochloride (HCl) Relative to One Dutasteride and One Tamsulosin HCl Tablet in Healthy Male Subjects
Condition:   Prostatic HyperplasiaInterventions:   Drug: Treatment A;   Drug: Treatment BSponsor:   GlaxoSmithKlineNot yet recruiting - verified July 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 23, 2015 Category: Research Source Type: clinical trials

Bioavailability Study of Fixed Dose Combination (FDC) Dutasteride and Tamsulosin Hydrochloride (HCl) Relative to One Dutasteride and One Tamsulosin HCl Tablet in Healthy Male Subjects
Condition:   Prostatic HyperplasiaInterventions:   Drug: FDC capsule of dutasteride and tamsulosin;   Drug: Dutasteride soft gelatine capsule and tamsulosin HCl oral disintegrating tabletSponsor:   GlaxoSmithKlineNot yet recruiting - verified July 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 23, 2015 Category: Research Source Type: clinical trials